CoChat

Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis

Open access
Kerr, David, Ahn, David, Waki, Kayo, Wang, Jing, Breznen, Boris, Klonoff, David C · 2024 · Journal of Medical Internet Research

Published version of a preprint

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 12 of the 17 sources its claims cite were checked for support.

Abstract

Background The proliferation of digital technology has the potential to transform diabetes management. One of the critical aspects of modern diabetes management remains the achievement of glycemic targets to avoid acute and long-term complications. Objective This study aims to describe the landscape of evidence pertaining to the relative effectiveness or efficacy and safety of various digital interventions for the self-management of type 2 diabetes mellitus (T2DM), with a primary focus on reducing glycated hemoglobin A1c (HbA1c) levels. Methods A systematic literature review (SLR) was conducted by searching Embase, MEDLINE, and CENTRAL on April 5, 2022. Study selection, data extraction, and quality assessment were performed by 2 independent reviewers. Eligibility criteria for the SLR included randomized controlled trials (RCTs) and comparative observational studies evaluating interventions containing both human (eg, coaching) and digital components (eg, glucose meter) in adult patients with T2DM. The primary meta-analysis was restricted to studies that reported laboratory-measured HbA1c. In secondary analyses, meta-regression was performed with the intensity of coaching in the digital intervention as a categorical covariate. Results In total, 28 studies were included in this analysis. Most studies (23/28, 82%) used the reduction of HbA1c levels as the primary end point, either directly or as a part of a multicomponent outcome. In total, 21 studies reported statistically significant results with this primary end point. When stratified into 3 intervention categories by the intensity of the intervention supporting the digital health technology (analyzing all 28 studies), the success rate appeared to be proportional to the coaching intensity (ie, higher-intensity studies reported higher success rates). When the analysis was restricted to RCTs using the comparative improvement of HbA1c levels, the effectiveness of the interventions was less clear. Only half (12/23, 52%) of the included RCTs reported statistically significant results. The meta-analyses were broadly aligned with the results of the SLR. The primary analysis estimated a greater reduction in HbA1c associated with digital interventions compared with usual care (–0.31%, 95% CI –0.45% to –0.16%; P<.001). Meta-regression estimated reductions of –0.45% (95% CI –0.81% to –0.09%; P=.02), –0.29% (95% CI –0.48% to –0.11%; P=.003), and –0.28% (95% CI –0.65% to 0.09%; P=.20) associated with high-, medium-, and low-intensity interventions, respectively. Conclusions These findings suggest that reducing HbA1c levels in individuals with T2DM with the help of digital interventions is feasible, effective, and acceptable. One common feature of effective digital health interventions was the availability of timely and responsive personalized coaching by a dedicated health care professional.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis of 28 studies found that digital interventions added to usual care were associated with a modest reduction in HbA1c in adults with type 2 diabetes. Coaching intensity appeared related to success, but among randomized controlled trials only about half showed a statistically significant comparative HbA1c reduction.

Key findings

  • Across 28 included studies, 21 (75%) reported statistically significant results for their primary end point; among the 23 RCTs, only 12 (52%) reported a statistically significant comparative reduction in HbA1c.
  • The primary random-effects meta-analysis (20 studies; n=1637 intervention vs n=1389 usual care) estimated a mean difference in HbA1c change of –0.31% (95% CI –0.45% to –0.16%; P<.001) favoring digital interventions.
  • Meta-regression estimated HbA1c reductions of –0.45% (95% CI –0.81% to –0.09%; P=.02) for high-intensity interventions, –0.29% (95% CI –0.48% to –0.11%; P=.003) for medium-intensity interventions, and –0.28% (95% CI –0.65% to 0.09%; P=.20) for low-intensity interventions.
  • Most studies reported ≤20% dropout, with >30% dropout in only 3 studies; 2 of 3 studies using the Diabetes Treatment Satisfaction Questionnaire reported significant improvement in the digital intervention groups.

Methods

  • Systematic literature review searched Embase, MEDLINE, and CENTRAL on April 5, 2022, plus conference abstracts from 2018-2022, selected company websites, and ClinicalTrials.gov; eligibility included RCTs and comparative observational studies of interventions with both human and digital components in adults >18 years with T2DM.
  • Two independent reviewers performed study selection, data extraction, and quality assessment, using the Cochrane risk of bias tool for RCTs and ROBINS-I for nonrandomized studies; 28 studies were included.
  • Random-effects meta-analyses examined mean difference in HbA1c change, with the primary analysis restricted to RCTs reporting laboratory-measured HbA1c; meta-regression used coaching intensity as a categorical covariate, with subgroup and sensitivity analyses.

Limitations

  • The paper states that the intensity-related conclusions require prospective testing; heterogeneity across interventions limits generalizability; boundaries between coaching categories were difficult to draw; meta-regression and subgroup analyses had low power due to few high- and low-intensity studies; follow-up time was not investigated; only RCTs were meta-analyzed, limiting real-world generalizability; all RCTs had some risk of bias; higher-intensity interventions may carry economic and logistical burdens; and behavior change was not measured appropriately.
  • The paper also notes poor adverse event reporting and a lack of clear differentiation between adherence and engagement.
  • The text makes evident that the sensitivity analysis excluding CGM studies was limited because only 2 CGM studies were included.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2196/55757

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) diagram.
Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) diagram.CC BY · PubMed Central
Figure 2 Forest plot of the MD and CI of change in HbA1c with meta-regression on intervention intensity. * indicate statistical significance. HbA1c: glycated hemoglobin A1c; MD: mean difference.
Figure 2 Forest plot of the MD and CI of change in HbA1c with meta-regression on intervention intensity. * indicate statistical significance. HbA1c: glycated hemoglobin A1c; MD: mean difference.CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 0 Not valid · 7 Not checked · 127 Own results and interpretations

77 more claims

Create a free account to see all 144 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 38
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

9 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Das, S, 2018, Indian J Endocrinol Metab, 22

Cited by

See all 101

Metadata

Authors
Kerr, D., Ahn, D., Waki, K., Wang, J., Breznen, B., & Klonoff, D. C.
Affiliations
  • Sutter Health (US)
  • The University of Tokyo (JP)
  • Florida State University (US)
  • BC Research (Canada) (CA)
Corresponding author
Kerr, David
Venue
Journal of Medical Internet Research
Published
2024-07-22
Volume
26
Pages
e55757
ISSN
1438-8871 (ISSN-L)
OpenAlex
W4396946832
Cited by
101
References
52
Citations by year
2026: 55 · 2025: 42 · 2024: 4
FWCI
9.05
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Medical Internet Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, digital health interventions, diabetes self-management, glycemic control, HbA1c, mobile health, blood glucose meters, intervention effectiveness, intervention safety, usual care comparison, diabetes complications prevention
MeSH terms
Self-Management, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Blood Glucose Self-Monitoring, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis. https://app.cochat.ai/papers/10.2196/55757
The paper
Kerr, D., Ahn, D., Waki, K., Wang, J., Breznen, B., & Klonoff, D. C. (2024). Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis. Journal of Medical Internet Research. https://doi.org/10.2196/55757

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.